相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Predicting Drug Metabolism by Cytochrome P450 2C9: Comparison with the 2D6 and 3A4 Isoforms
Patrik Rydberg et al.
CHEMMEDCHEM (2012)
Crystal Structure of Human Cytochrome P450 2D6 with Prinomastat Bound
An Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
RS-Predictor Models Augmented with SMARTCyp Reactivities: Robust Metabolic Regioselectivity Predictions for Nine CYP Isozymes
Jed Zaretzki et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Quantum Mechanically Derived AMBER-Compatible Heme Parameters for Various States of the Cytochrome P450 Catalytic Cycle
Kiumars Shahrokh et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2012)
Substituted Imidazole of 5-Fluoro-2-[4-[(2-phenyl-1H-imidazol-5yl)methyl]-1-piperazinyl]pyrimidine Inactivates Cytochrome P450 2D6 by Protein Adduction
Leslie D. Nagy et al.
DRUG METABOLISM AND DISPOSITION (2011)
The SMARTCyp cytochrome P450 metabolism prediction server
Patrik Rydberg et al.
BIOINFORMATICS (2010)
Identification of Novel Metoclopramide Metabolites in Humans: In Vitro and In Vivo Studies
Upendra A. Argikar et al.
DRUG METABOLISM AND DISPOSITION (2010)
Mechanism-based inactivation of human cytochromes P450s: Experimental characterization, reactive intermediates, and clinical implications
Paul F. Hollenberg et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
A semiempirical free energy force field with charge-based desolvation
Ruth Huey et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2007)
Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions
R. Scott Obach et al.
DRUG METABOLISM AND DISPOSITION (2007)
In silico prediction of drug binding to CYP2D6:: Identification of a new metabolite of metoclopramide
Jinglei Yu et al.
DRUG METABOLISM AND DISPOSITION (2006)
Crystal structure of human cytochrome P450 2D6
P Rowland et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mechanism-based inactivation of cytochrome P450 2D6 by 1-[(2-Ethyl-4-methyl-1H-imidazol-5-yl)methyl]-4-[4-(trifluoromethyl)-2-pyridinyl]piperazine: Kinetic characterization and evidence for apoprotein adduction
JM Hutzler et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2004)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Drug-protein adducts: An industry perspective on minimizing the potential for drug bioactivation in drug discovery and development
DC Evans et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2004)
Mechanism-based inactivation of CYP2D6 by methylenedioxymethamphetamine
A Heydari et al.
DRUG METABOLISM AND DISPOSITION (2004)
Apparent mechanism-based inhibition of human CYP2D6 in vitro by paroxetine: Comparison with fluoxetine and quinidine
KM Bertelsen et al.
DRUG METABOLISM AND DISPOSITION (2003)
The gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6
Z Desta et al.
DRUG METABOLISM AND DISPOSITION (2002)
Heterologous expression of cytochrome P450 2D6 mutants, electron transfer, and catalysis of bufuralol hydroxylation: The role of aspartate 301 in structural integrity
IH Hanna et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2001)
分享论文
